Dr. G interviews Dr. Dawn Franceschina, a physical therapist and Vice Chair of the ABWM Foundation, about her 29-year career in wound care, advances in treatment, and the importance of Wound Healing Awareness Month.

The episode highlights the PT perspective, interdisciplinary limb-salvage teamwork, board certification, common barriers to healing, and practical steps for clinicians, patients, and industry to get involved.

This episode explores how diabetic foot ulcers affect not just health but work and identity. Dr. G explains common patient fears about income, insurance, and being seen as unreliable, and how employers usually evaluate function, safety, and attendance rather than diagnosis alone.

Learn practical advice on medical documentation, workplace accommodations, timing of work restrictions, and the importance of clear communication to protect both the patient’s health and long-term employment.

Dr. G dives into the complex reality of disability for people with diabetic foot ulcers — explaining why a diagnosis alone doesn’t determine disability, how occupation, ulcer characteristics, infection, blood flow, blood sugar, pressure, offloading, nutrition, and smoking affect healing, and why return-to-work decisions focus on function rather than timelines.

This episode emphasizes empathetic communication, accurate documentation, realistic expectations, and the difference between temporary and permanent disability, offering a clear view of why healing varies and how clinicians and patients can work together toward recovery.

Dr. G explores the "Preventability Index," a framework for replaying a patients timeline to identify missed opportunities that could have prevented a diabetic foot ulcer or amputation. He explains the five domains of the index—structural deformity, skin integrity, infection burden, vascular reserve, and time to intervene—each scored 010; higher totals indicate greater preventability.

The episode emphasizes prevention through early detection, foot exams during routine visits, patient education, timely vascular and infection evaluation, and offloading. Dr. G stresses that the index is not for blame but for quality improvement and patient advocacy to reduce avoidable limb loss.

A 62-year-old man with poorly controlled diabetes presented with weeks of cough, weight loss, night sweats, and cavitary lung lesions initially suspected to be tuberculosis or malignancy. Sputum TB tests were negative and symptoms progressed.

Bronchoscopic lung biopsy showed branching gram‑positive filaments that were weakly acid‑fast, consistent with Nocardia species. Nocardia commonly infects immunocompromised hosts, can disseminate to the brain, and is often mistaken for TB, fungal infection, or cancer. Diagnosis relies on modified acid‑fast stain, prolonged cultures, or molecular testing.

Treatment requires prolonged antibiotic therapy (commonly TMP‑SMX), sometimes IV agents for severe disease, and early recognition in diabetic or immunosuppressed patients is critical to prevent dissemination.

Imagine a patient with no complaints whose foot hair has vanished. This episode explains the "hair test"—how absent hair on the toes and feet can be an early bedside clue to poor circulation, peripheral arterial disease, and limb-threatening ischemia in people with diabetes.

It reviews hair follicle biology, how reduced blood flow interrupts hair growth, associated skin and nail changes, limitations of the sign (aging, genetics, friction, shaving), and practical next steps including pulse exam, Doppler, ABI/toe pressures, and vascular referral. Hair is a quick clue, not a diagnosis.

This episode of Diabetic Foot Files dives into nystatin: its history, how it kills Candida, and why it often works for moist, macerated toe-web infections but fails against dermatophyte-caused athlete's foot.

Dr. G explains the importance of delivery method (powder vs. cream/ointment), diabetic risk factors like moisture and hyperglycemia, and practical prevention tips for patients.

The episode also covers real-world issues such as supply shortages and cost, plus effective OTC alternatives and when to seek professional evaluation.

In this episode of Diabetic Foot Files, Dr. G explores Zaynich (cefepime + ZD-bactam), a newly FDA-approved IV antibiotic designed to overcome multi-drug resistant gram-negative infections. He explains the drug's dual-target mechanism, its potential role in limb salvage for severe diabetic foot infections, common side effects, dosing, current FDA indications, and when to involve infectious disease specialists.

Listeners will learn why this combination may be a game-changer for difficult-to-treat infections, the importance of antibiotic stewardship, and practical considerations for use in wound care and limb salvage scenarios.